Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
- 6 January 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (575)
- https://doi.org/10.1126/scitranslmed.aba6110
Abstract
Although chemotherapeutic agents have been used for decades, the mechanisms of action, mechanisms of resistance, and the best treatment schedule remain elusive. Mitomycin C (MMC) is the gold standard treatment for non–muscle-invasive bladder cancer (NMIBC). However, it is effective only in a subset of patients, suggesting that, aside from cytotoxicity, other mechanisms could be involved in mediating the success of the treatment. Here, we showed that MMC promotes immunogenic cell death (ICD) and in vivo tumor protection. MMC-induced ICD relied on metabolic reprogramming of tumor cells toward increased oxidative phosphorylation. This favored increased mitochondrial permeability leading to the cytoplasmic release of mitochondrial DNA, which activated the inflammasome for efficient IL-1β (interleukin-1β) secretion that promoted dendritic cell maturation. Resistance to ICD was associated with mitochondrial dysfunction related to low abundance of complex I of the respiratory chain. Analysis of complex I in patient tumors indicated that low abundance of this mitochondrial complex was associated with recurrence incidence after chemotherapy in patients with NMIBC. The identification of mitochondria-mediated ICD as a mechanism of action of MMC offers opportunities to optimize bladder cancer management and provides potential markers of treatment efficacy that could be used for patient stratification.Keywords
Funding Information
- European Research Council
- Ministero della Salute (GR-2013-02358222)
- Associazione Italiana per la Ricerca sul Cancro
- Associazione Italiana per la Ricerca sul Cancro
This publication has 63 references indexed in Scilit:
- Combination of glycolysis inhibition with chemotherapy results in an antitumor immune responseProceedings of the National Academy of Sciences of the United States of America, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during ApoptosisImmunity, 2012
- Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture modelGut, 2012
- What is the mitochondrial permeability transition pore?Journal of Molecular and Cellular Cardiology, 2009
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiationProceedings of the National Academy of Sciences of the United States of America, 2009
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell deathThe EMBO Journal, 2009
- Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion ChannelsPLOS ONE, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005